We Make Healthcare
Understandable, Accessible and Affordable.
R & D Biotechnology
Daser Tekstil boasts a cutting-edge R&D facility designed for the extraction, isolation, and purification of products derived from the upstream (fermentation) process. This state-of-the-art facility features scaled-down versions of major equipment found in our manufacturing plants, ensuring exceptional flexibility during process scale-up. Equipped with a comprehensive array of tools for complex organic synthesis chemistry, our R&D facility includes essential equipment such as various filtration units—Microfiltration, Ultrafiltration, and Nanofiltration—as well as column chromatography and diverse filtration systems.
With a focus on innovation and efficiency, Daser Tekstil’ R&D facility serves as a hub for pioneering research and development initiatives. Beyond its advanced equipment capabilities, our facility fosters collaboration and creativity, enabling our team to explore novel solutions and drive progress in biotechnology. From optimizing processes to developing new methodologies, we are committed to pushing the boundaries of what’s possible, shaping the future of biotechnology with each breakthrough discovery.
Here are some of the activities conducted at Daser Tekstil' R&D department:
- Crafting downstream processes for novel APIs and intermediates, with a clear aim of commercialization within set timeframes.
- Streamlining processes from R&D to pilot and commercial scales, optimizing efficiency and scalability.
- Continuous enhancement of processes to bolster overall yield and cost-effectiveness.
- Innovating non-infringing processes to facilitate product launches while adhering to legal requirements.
- Executing Contract Research & Manufacturing projects with a strong focus on punctual completion and quality assurance.
At Daser Tekstil, our R&D endeavors encompass a wide array of activities aimed at fostering innovation and commercialization within specified timeframes. This includes the development of downstream processes for novel APIs and intermediates, with a keen focus on their eventual commercialization. Our dedicated team is committed to optimizing processes and seamlessly scaling them up from the R&D phase to pilot and commercial production, ensuring efficiency and reliability at each stage of development.